DJW Kangyuan Pharmaceutical Group

Qingdao Kangyuan Pharmaceutical is a leading Chinese biopharmaceutical company specializing in the research, development, and large-scale production of biochemical APIs and finished dosage forms. As a subsidiary of Qingdao Jiulong Biopharmaceutical, the company is recognized as a global leader in the production of hormone-based therapies and thrombolytic agents, including urokinase and human menopausal gonadotropin (HMG). Their product portfolio primarily addresses critical needs in reproductive health, cardiovascular emergency care, and metabolic disorders. With GMP-compliant facilities and a strong focus on high-purity extraction and synthesis, Kangyuan serves as a key supplier to pharmaceutical partners worldwide.